Company Filing History:
Years Active: 2024
Title: Yeon-Woo Son: Innovator in Pharmaceutical Compounds
Introduction
Yeon-Woo Son is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug compounds.
Latest Patents
Yeon-Woo Son holds 1 patent for his invention titled "Monomethyl fumarate precursor drug compounds and pharmaceutical compositions thereof." This patent presents innovative compounds capable of producing monomethyl fumarate after administration. The pharmaceutical compositions derived from these compounds serve as active ingredients and have potential applications in treating or alleviating various diseases, including immune system abnormalities, neurodegeneration, and inflammatory diseases.
Career Highlights
Son is currently associated with Agathonbio Co., Ltd., where he continues to advance his research and development efforts in the pharmaceutical sector. His work focuses on creating effective treatments that address critical health issues.
Collaborations
One of his notable coworkers is Hyung-chul Ryu, with whom he collaborates on various projects within the company.
Conclusion
Yeon-Woo Son's innovative work in pharmaceutical compounds highlights his commitment to improving healthcare through scientific advancements. His contributions are paving the way for new treatments that could significantly impact patient care.